Solid Solution Lipid Adjuvant Delivery for Severe Pain
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current therapies for severe pain are limited, often requiring multiple medications with undesirable systemic side effects and providing unsatisfactory relief, failing to restore quality of life effectively.
Innovation Solution
Development of solid solution pharmaceutical compositions that utilize a lipid-adjuvant delivery system to effectively inhibit pain responses by formulating therapeutic compounds with room temperature solid and liquid lipids, stabilizing agents, and neutralizing agents, allowing for targeted delivery to cells and tissues.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If multiple medications are administered to treat severe pain, then pain relief is attempted, but systemic side effects and drug interactions increase
Solution Approach 1:
The invention segments the therapeutic approach by using a lipid-adjuvant delivery system that targets pain pathways specifically, rather than using multiple systemic medications. The composition divides the treatment into targeted delivery of therapeutic compounds through lipid carriers, which reduces exposure of non-target tissues to medications.
Solution Approach 2:
The lipid-adjuvant acts as an intermediary carrier that delivers therapeutic compounds to pain pathways. This mediator system allows the therapeutic compound to reach its target more selectively, reducing the need for multiple medications and minimizing systemic side effects and drug interactions.
2Adaptability or versatility
If multiple medications are used for severe pain, then various pain pathways are targeted, but treatment complexity increases
Solution Approach 1:
The lipid-adjuvant delivery system serves multiple functions: it delivers therapeutic compounds, targets pain pathways, and provides sustained release. This multi-functional approach allows a single composition to address various pain pathways without requiring multiple separate medications or complex treatment regimens.
Solution Approach 2:
The invention merges the therapeutic compound with the lipid-adjuvant into a single pharmaceutical composition. This combination integrates multiple functions (delivery, targeting, sustained release) into one treatment system, simplifying the overall treatment approach while maintaining versatility in pain pathway coverage.
3Reliability
If current pain therapies are used, then some pain relief is achieved, but quality of life restoration is insufficient
Solution Approach 1:
The lipid-adjuvant delivery system is designed to provide sustained release of therapeutic compounds, acting in advance to maintain effective concentrations over time. This preliminary action ensures continuous pain relief without requiring frequent dosing, thereby improving quality of life restoration.
Solution Approach 2:
The composition provides continuous therapeutic action through the lipid-adjuvant's sustained release mechanism. This continuity ensures consistent pain relief and maintains quality of life improvement over an extended period, rather than providing intermittent relief that requires frequent re-dosing.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The compositions provide sustained pain relief with minimized systemic side effects and drug interactions, effectively reducing pain responses by inhibiting pain pathways at the cellular level.
Implementation Method 1
contacting a therapeutic compound disclosed herein with one or more room temperature liquid lipids under conditions which allow the therapeutic compound to dissolve in the lipids
Implementation Method 2
heat is applied to dissolve the therapeutic compound into the one or more room temperature liquid lipids to create a solution
Implementation Method 3
contacting the compound/lipid solution with one or more room temperature solid lipids under conditions which allow the formation of a solid solution composition
Data Source
AI summary
The present specification discloses pharmaceutical compositions, methods of preparing such pharmaceutical compositions, and methods and uses of treating a severe pain in an individual using such pharmaceutical compositions.